Skip to main content

Suraksha Diagnostic Ltd

NSE: SURAKSHA BSE: 544293Healthcare

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]

298
52W: ₹224 — ₹354
PE 43.9 · Book ₹45 · +562% vs book
Market Cap₹1,554 Cr
Stock P/E43.9Price to Earnings
ROCE18.5%Return on Capital
ROE17.1%Return on Equity
Div. Yield0%Face Value ₹2

Weaknesses

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 9.60% over past five years.
  • Company has a low return on equity of 13.3% over last 3 years.

Shareholding Pattern

Promoters49.1%
FIIs13.46%
DIIs23.14%
Public14.31%
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters48.78%48.78%48.89%0.148.98%0.149%0.049.1%0.1
FIIs15.39%14.46%0.913.95%0.513.73%0.213.46%0.313.46%
DIIs20.43%22.05%1.622.37%0.321.98%0.422.57%0.623.14%0.6
Public15.39%14.71%0.714.79%0.115.3%0.514.98%0.314.31%0.7

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales60.0551.4555.3760.4365.9558.5764.1570.2876.2675.58
Expenses3935.8735.4439.3242.3940.4844.3346.4552.2952.39
Operating Profit21.0515.5819.9321.1123.5618.0919.8223.8323.9723.19
OPM %35.05%30.28%35.99%34.93%35.72%30.89%30.9%33.91%31.43%30.68%
Net Profit8.654.936.848.3310.756.368.019.859.368.14
EPS ₹125.3671.4599.131.932.491.221.541.891.81.56

AI Insights

Revenue Trend

TTM revenue at ₹286Cr, up 14.9% YoY. OPM at 32%.

Debt Position

Borrowings at ₹115Cr. Debt-to-equity ratio: 0.51x. Moderate leverage.

Capex Cycle

CWIP at ₹2Cr (1% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 23.14% (+2.71pp change). FIIs: 13.46% (-1.93pp change). Promoters hold 49.1%.

Margin & Efficiency

ROCE improving from 0% (Mar 2018) to 18% (Mar 2025). Working capital days: -14.

Valuation

PE 43.9x with 18.5% ROCE. Price is 562% above book value of ₹45. Dividend yield: 0%.

Recent Announcements